NASDAQ:CELH - Celsius Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.97 -0.02 (-0.40 %)
(As of 03/20/2019 01:17 AM ET)
Previous Close$4.99
Today's Range$4.83 - $4.99
52-Week Range$3.05 - $5.63
Volume77,531 shs
Average Volume68,415 shs
Market Capitalization$254.44 million
P/E Ratio-21.61
Dividend YieldN/A
Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of calorie-burning beverages. It offers flavors including grapefruit, cucumber lime, orange pomegranate, pineapple coconut, watermelon berry, and strawberries and cream. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Receive CELH News and Ratings via Email

Sign-up to receive the latest news and ratings for CELH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bottled & canned soft drinks
SectorConsumer Staples
Current SymbolNASDAQ:CELH



Sales & Book Value

Annual Sales$52.60 million
Book Value$0.23 per share


Net Income$-11,210,000.00


Market Cap$254.44 million
Next Earnings Date5/9/2019 (Estimated)
OptionableNot Optionable

Celsius (NASDAQ:CELH) Frequently Asked Questions

What is Celsius' stock symbol?

Celsius trades on the NASDAQ under the ticker symbol "CELH."

How were Celsius' earnings last quarter?

Celsius Holdings, Inc. (NASDAQ:CELH) announced its quarterly earnings data on Thursday, March, 14th. The company reported ($0.02) earnings per share for the quarter, hitting the consensus estimate of ($0.02). The company earned $14.68 million during the quarter, compared to analyst estimates of $11.20 million. Celsius had a negative return on equity of 90.06% and a negative net margin of 21.39%. View Celsius' Earnings History.

When is Celsius' next earnings date?

Celsius is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for Celsius.

What price target have analysts set for CELH?

2 equities research analysts have issued twelve-month price objectives for Celsius' stock. Their predictions range from $7.00 to $8.00. On average, they anticipate Celsius' stock price to reach $7.50 in the next twelve months. This suggests a possible upside of 50.9% from the stock's current price. View Analyst Price Targets for Celsius.

What is the consensus analysts' recommendation for Celsius?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celsius in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Celsius.

What are Wall Street analysts saying about Celsius stock?

Here are some recent quotes from research analysts about Celsius stock:
  • 1. Maxim Group analysts commented, "Market open, CELH reported better-than-expected 4Q18 results, including domestic revenue above our estimate. GAAP loss per share was narrower-than-expected as CELH scaled back its China investment ahead of its transition to a licensing strategy. We are raising topline estimates on the revenue beat, but reducing EPS estimates on higher expected marketing and promotional investments." (3/14/2019)
  • 2. According to Zacks Investment Research, "Celsius Holdings, Inc. specializes in commercializing healthier, nutritional functional foods, beverages and dietary supplements. Celsius Holdings, Inc. markets Celsius®, the calorie burner, through its wholly-owned operating subsidiary, Celsius, Inc. The Company sells its products through grocery, drug, convenience, club and mass, and health and fitness channels. The Company's products are produced in Mooresville, North Carolina, and Monroe, Wisconsin. Celsius, Inc. is dedicated to providing healthier, everyday refreshment through science and innovation. The Company serves customers in the United States and internationally. Celsius Holdings, Inc. is based in Delray Beach, Florida. " (2/5/2019)

Has Celsius been receiving favorable news coverage?

News articles about CELH stock have trended very positive on Wednesday, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Celsius earned a news impact score of 3.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the near future.

Who are some of Celsius' key competitors?

What other stocks do shareholders of Celsius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celsius investors own include AVEO Pharmaceuticals (AVEO), Novavax (NVAX), UQM Technologies (UQM), Viewray (VRAY), Visa (V), Corbus Pharmaceuticals (CRBP), Synlogic (SYBX), GTX (GTXI), Abraxas Petroleum (AXAS) and Genocea Biosciences (GNCA).

Who are Celsius' key executives?

Celsius' management team includes the folowing people:
  • John Fieldly, President, Chief Executive Officer & Director
  • Edwin Negrón-Carballo, Chief Financial Officer
  • Roberta Kotkosky, Vice President-Domestic Sales
  • Linda Loren-Gulla, Vice President-Marketing
  • Matthew Kahn, Executive Vice President-Marketing

Who are Celsius' major shareholders?

Celsius' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.25%), Geode Capital Management LLC (0.34%), Geode Capital Management LLC (0.34%), Anchor Capital Advisors LLC (0.31%), GYL Financial Synergies LLC (0.20%) and Granite Investment Partners LLC (0.17%). View Institutional Ownership Trends for Celsius.

Which institutional investors are selling Celsius stock?

CELH stock was sold by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC and Granite Investment Partners LLC. View Insider Buying and Selling for Celsius.

Which institutional investors are buying Celsius stock?

CELH stock was bought by a variety of institutional investors in the last quarter, including GYL Financial Synergies LLC, Geode Capital Management LLC, Geode Capital Management LLC, Rhumbline Advisers and BlackRock Inc.. View Insider Buying and Selling for Celsius.

How do I buy shares of Celsius?

Shares of CELH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Celsius' stock price today?

One share of CELH stock can currently be purchased for approximately $4.97.

How big of a company is Celsius?

Celsius has a market capitalization of $254.44 million and generates $52.60 million in revenue each year. The company earns $-11,210,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.

What is Celsius' official website?

The official website for Celsius is

How can I contact Celsius?

Celsius' mailing address is 2424 N. FEDERAL HWY SUITE 208, BOCA RATON FL, 33431. The company can be reached via phone at 561-276-2239 or via email at [email protected]

MarketBeat Community Rating for Celsius (NASDAQ CELH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  232
MarketBeat's community ratings are surveys of what our community members think about Celsius and other stocks. Vote "Outperform" if you believe CELH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel